HomeNEU • ASX
add
Neuren Pharmaceuticals Ltd
Previous close
$12.35
Day range
$12.02 - $12.25
Year range
$10.65 - $25.95
Market cap
1.57B AUD
Avg Volume
504.68K
P/E ratio
13.37
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 12.16M | -61.34% |
Operating expense | 1.19M | -22.01% |
Net income | 4.01M | -83.23% |
Net profit margin | 32.95 | -56.63% |
Earnings per share | — | — |
EBITDA | 2.04M | -91.54% |
Effective tax rate | 32.31% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 213.17M | 148.82% |
Total assets | 228.15M | 133.95% |
Total liabilities | 9.00M | 49.73% |
Total equity | 219.15M | — |
Shares outstanding | 127.82M | — |
Price to book | 7.22 | — |
Return on assets | 2.23% | — |
Return on capital | 2.32% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 4.01M | -83.23% |
Cash from operations | -10.27M | -145.76% |
Cash from investing | 420.00K | 101.78% |
Cash from financing | 825.50K | 50.50% |
Net change in cash | -7.26M | -710.89% |
Free cash flow | 1.66M | -89.35% |
About
CEO
Founded
2001
Website
Employees
8
